Trinity Legacy Partners, LLC Gilead Sciences, Inc. Transaction History

Trinity Legacy Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Jan 20, 2021	SELL	$56.65 - $64.55 $2.24 Million - $2.55 Million	-39,568 Closed	0 $0
Q3 2020 Oct 15, 2020	BUY	$62.1 - $78.08 $43,656 - $54,890	703 Added 1.81%	39,568 $2.55 Million
Q2 2020 Jul 08, 2020	BUY	$72.34 - $84.0 $54,761 - $63,588	757 Added 1.99%	38,865 $2.98 Million
Q1 2020 Apr 06, 2020	BUY	$62.63 - $80.22 $2.07 Million - $2.65 Million	33,093 Added 659.88%	38,108 $2.93 Million
Q4 2019 Jan 10, 2020	BUY	$61.62 - $67.78 $309,024 - $339,916	5,015 New	5,015 $330,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Trinity Legacy Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Trinity Legacy Partners, LLC with notifications on news.